Showing 1 - 2 of 2 results
Class (Stereo):
CHEMICAL (ACHIRAL)
Targets:
Ataluren (Translarna) is a small-molecule drug approved in Europe for the treatment of Duchenne muscular dystrophy caused by a nonsense mutation. Ataluren interacts with the ribosome enabling it to read through premature nonsense stop signals on mRNA...